A Randomized Controlled Trial of Mindfulness in Recovery from Colorectal Cancer.
Study Goal
The researchers aimed to determine if a 4-week mindfulness intervention was more effective than a psychoeducation and cognitive behavioral skills control group in reducing psychological distress in colorectal cancer patients.
Results Summary
Mindfulness was not superior to the active control in reducing psychological distress, but both groups showed improvements in depression. The mindfulness group had specific benefits in disease-specific QoL (e.g., reduced impotence symptoms), while the control group showed better generic mental QoL and reduced faecal incontinence. Both interventions were rated as credible and acceptable.
Population
Colorectal cancer (CRC) patients
Effective Dosage
2-hour weekly sessions
Duration
4 weeks
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
4-week group-based mindfulness intervention | no change | psychological distress | colorectal cancer (CRC) patients | - | was not superior to the active control group in terms of alleviating | #1 |
mindfulness | no change | alleviating psychological distress | colorectal cancer (CRC) patients | - | was not superior to | #2 |
mindfulness | decrease | depression scores | colorectal cancer (CRC) patients | - | reduced | #3 |
active control group | decrease | depression scores | colorectal cancer (CRC) patients | - | reduced | #4 |
active control group | increase | generic mental QoL scores | colorectal cancer (CRC) patients | - | had greater improvement in | #5 |
mindfulness group | decrease | impotence symptom | colorectal cancer (CRC) patients | - | reduction in | #6 |
control group | decrease | faecal incontinence | colorectal cancer (CRC) patients | - | reduction in | #7 |
mindfulness group | increase | embarrassment symptom | colorectal cancer (CRC) patients | - | had a significantly lower increase in | #8 |
mindfulness | no change | credible and acceptable | colorectal cancer (CRC) patients | - | rated as | #9 |
active control group | no change | credible and acceptable | colorectal cancer (CRC) patients | - | rated as | #10 |
mindfulness | decrease | depression | colorectal cancer (CRC) patients | - | associated with some improvements in | #11 |
active control group | decrease | depression | colorectal cancer (CRC) patients | - | associated with some improvements in | #12 |
OBJECTIVE: This study examined whether a 4-week group-based mindfulness intervention would be superior in reducing psychological distress in colorectal cancer (CRC) patients compared to a psychoeducation and cognitive behavioural skills learning support active control group. METHODS: Patients with CRC were randomized via Computerised Permuted Block Randomisation to mindfulness or active control groups (2-h weekly sessions over 4 weeks). Outcomes were measured pre-intervention, and 8 weeks and 6 months post-baseline. The primary outcome was psychological distress measured by the Hospital Anxiety and Depression Scale. Secondary outcomes were generic quality of life (QoL), disease specific QoL, mindfulness, and intervention credibility and acceptability. RESULTS: Sixty-eight participants were randomized to mindfulness (n=35) or active control group (n=33). Uptake of potentially eligible patients consenting was low (28.0%) and the dropout rate was 33.8%. Depression scores were reduced in both groups at week 8 (P=0.020). Control participants had greater improvement in generic mental QoL scores at week 8 than mindfulness (P=0.023). In disease specific QoL, there was reduction in impotence symptom in the mindfulness group (P=0.022) and reduction in faecal incontinence in the control group (P=0.019). The embarrassment symptom had a significantly lower increase in the mindfulness group at week 8 compared to the control group (P=0.009). Both groups rated the treatments as credible and acceptable. CONCLUSIONS: Mindfulness was not superior to the active control group in terms of alleviating psychological distress but both treatments were associated with some improvements in depression. There was low uptake of both interventions. (Trial registration number: ACTRN12616001033437).